-
-
-
-
-
-
-
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
-
-
-
-
-
-
-
Form SC 13G/A Bioventus Inc. Filed by: EW HEALTHCARE PARTNERS ACQUISITION FUND, L.P.
-
-
-
-
-
-
-
Bioventus Announces CEO Leadership Change
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, IBM, and FATE and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
-
-
-
-
-
-
-
Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance
-
-
-
-
-
-
-
Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

